SRPX2 and Whooping cough: Future improved whooping cough vaccines could benefit from comprising Bp-Bpp cross-reacting antigens explicitly, such as the adenylate cyclase [60] or conserved antigens identified through immuno-informatics [61], or could incorporate Bpp-specific antigens, such as the O-antigen [62].